European and North Indian Cohort of KaWasaki dIsease

Recruiting Observational Study
Kawasaki Disease
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 – 17
Sex
Any
Study type
Observational
Participants needed
103 (estimated)
Sponsor
Meyer Children's Hospital IRCCS · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Kawasaki disease (KD) is currently the leading cause of acquired heart diseases in children in developed countries. Cardiac involvement is the main determinant of the long-term prognosis of these patients, as coronary aneurisms (CAAs) may lead to ischemic heart disease and even sudden death. The current standard of care for KD has consistently reduced CAAs frequency from 25-30% to about 5%. Unfort…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients aged less than 18 years at diagnosis * Diagnosis of KD according to the AHA criteria Exclusion Criteria: * Patients who do not meet the criteria for KD * Patients for which an alternative infectious diagnosis was not investigated and/or excluded.
Contacts

Gabriele Simonini

3297973141

gabriele.simonini@meyer.it

CONTACT